Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Joint Bone Spine|February 9, 2019
Increased incidence of spondyloarthropathies in patients with Takayasu arteritis: a systematic clinical surveySakine Güzel Esen, Berkan Armagan, Nuh Atas, et al.
Turkish Journal of Medical Sciences|October 28, 2019
Anti-interleukin-6 (tocilizumab) therapy in Takayasu's arteritis: a real life experienceLevent Kılıç, Ömer Karadağ, Abdulsamet Erden, et al.
Clinical and Experimental Rheumatology|February 26, 2021
Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO RegistryBayram Farisoğulları, Gözde Kübra Yardımcı, Alper Sarı, et al.
Clinical and Experimental Rheumatology|September 10, 2019
Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registryEmre Bilgin, Bayram Farisoğulları, Berkan Armağan, et al.
Turkish Journal of Medical Sciences|September 27, 2020
Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experienceEmre Bilgin, Furkan Ceylan, Emine Duran, et al.
Current Medical Research and Opinion|March 28, 2025
Comparison of functionality, mood, and biopsychosocial status in rheumatic patients with and without self-reported bowel problems and the evaluation of BETY's impact on these factors: a retrospective studyNur Banu Karaca, Aysu Kahraman, Sinan Buran, et al.
Turkish Journal of Medical Sciences|July 21, 2023
Pulmonary hypertension in Behçet's disease: echocardiographic screening and multidisciplinary approachBerkan Armağan, Metin Okşul, Yusuf Ziya Şener, et al.
Clinical Rheumatology|January 28, 2022
Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry resultsGizem Ayan, Bayram Farisogulları, Emre Bilgin, et al.
Turkish Journal of Medical Sciences|November 21, 2017
The clinical features and outcomes of Turkish patients with IgG4-related disease:a single-center experienceÖmer Karadağ, Abdulsamet Erden, Emine Arzu Ayhan, et al.
Immunity, Inflammation and Disease|December 22, 2023
Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypesDuygu Temiz Karadağ, Andac Komac, Yesim Erez, et al.
Pageof 5